Acute Kidney Injury(AKI), ๊ธ‰์„ฑ ์‹ ๋ถ€์ „

1. Etiology

AKI์˜ ๋ถ„๋ฅ˜

  • Hemodynamic (prerenal) : ํ˜ˆ๋ฅ˜์—ญํ•™์  ๋ฐœ์ƒ. ์‹ ์žฅ์œผ๋กœ์˜ ๊ด€๋ฅ˜๋Ÿ‰ ๊ฐ์†Œ โ†’ ์ฒด์•ก๋Ÿ‰ ๋ณด์กด์„ ์œ„ํ•ด GFR ๊ฐ์†Œ
  • Parenchymal (intrinsic) : ์‹ ์žฅ ์‹ค์งˆ์˜ ์ด์ƒ์— ์˜ํ•ด ๋ฐœ์ƒ. ๊ฐ์—ผ์„ฑ ์งˆํ™˜, ๋…์†Œ, ์ „์‹  ์งˆํ™˜ ๋“ฑ. ๊ธฐ์ € ์›์ธ์„ ์ œ๊ฑฐํ•˜๋Š” ๊ฒƒ์ด ์œ ์ผํ•œ ๋ฐฉ๋ฒ•.
  • Postrenal : ์‹ ์žฅ ์ดํ›„ ๊ธฐ๊ด€์— ์˜ํ•ด ๋ฐœ์ƒ.์š”๋„ ํ์ƒ‰(urethral obstruction), ์‹ ์žฅ ์–‘์ธก์„ฑ/ํŽธ์ธก์„ฑ ์š”๊ด€(ureteral) ํ์ƒ‰, ์š”๋กœ๊ณ„ ์ผ๋ถ€ ํŒŒ์—ด(rupture) ๋“ฑ์— ์˜ํ•ด urine flow๊ฐ€ ๋ง‰ํž˜. ๋„ˆ๋ฌด ์˜ค๋ž˜ ์ง€์†๋˜๋ฉด ์˜๊ตฌ์  ์‹ค์งˆ ์†์ƒ ๊ฐ€๋Šฅ.

2. Pathophysiology

AKI์˜ ์ž„์ƒ์  ๋‹จ๊ณ„

PhaseํŠน์ง•
Latent phase- ์‹ ์žฅ ๋…์†Œ๋‚˜ ํ—ˆํ˜ˆ์— ๋…ธ์ถœ๋œ ์ดํ›„๋ถ€ํ„ฐ azotemia์˜ ๋ฐœ์ƒ ์ „.
- ์ž„์ƒ ์ฆ์ƒ์ด ์—†์–ด ํ™•์ธ์ด ์–ด๋ ค์›€.
- ์•„์ง ํšŒ๋ณต ๊ฐ€๋Šฅ์„ฑ ๋†’์Œ.
Maintenance phase- ์ž„์ƒ์ ์œผ๋กœ ์œ ์˜๋ฏธํ•œ ์†์ƒ์ด ๋‚˜ํƒ€๋‚จ.
- ๋ฌด๋‡จ, ํ•๋‡จ, ์†Œ๋ณ€์–‘ ๋ณ€ํ™” ์—†์Œ, ๋‹ค๋‡จ ๋“ฑ ๋‚˜ํƒ€๋‚จ.
- ์‹ ์žฅ ๊ธฐ๋Šฅ ํšŒ๋ณต๊นŒ์ง€ 1-3์ฃผ ์†Œ์š”, ์‹ ์žฅ ์ˆ˜์น˜๊ฐ€ ์ž˜ ํšŒ๋ณต๋˜์ง€ ์•Š๊ฑฐ๋‚˜ ์œ ์ง€๋จ.
Recovery phase- BUN, SCr์ด ์ •์ƒ์œผ๋กœ ๋Œ์•„์˜ค๊ณ , ํ˜ˆ๋ฅ˜ ํ๋ฆ„์ด ํšŒ๋ณต๋จ.
- ์†์ƒ๋„์— ๋”ฐ๋ผ ์†Œ์ˆ˜๋Š” CKD๋กœ ์ง„ํ–‰๋  ์ˆ˜ ์žˆ์Œ.

AKI์˜ ์›์ธ (in dogs & cats)

Nephrotoxins (์‹ ์žฅ ๋…์†Œ)
  • Ethylene glycol
  • aminoglycosides
  • amphotericin B
  • easter lily (cats)
  • grape/raisin (dogs)
  • hypercalcemia : cholecalciferol rodenticide, calcipotriene (dovonex)
  • anticancer drugs : cisplatin
  • radiocontrast dyes
  • ์ค‘๊ธˆ์†(heavy metals)
  • tainted food
  • hydroxyethyl starch
NephrotoxinsRenal ischemiaOthers
Ethylene glycoldehydrationLeptospirosis
aminoglycosidestraumaBorrelia
amphotericin Banesthesiarenal glomerular
vasculopathy
easter lily (cats)sepsis
grape/raisin (dogs)heat stoke
hypercalcemia
: cholecalciferol rodenticide
: calcipotriene (dovonex)
pigment nephropathy
: Myoglobinuria
anticancer drugs (cisplatin)shock
radiocontrast dyeshemorrhage
์ค‘๊ธˆ์†(heavy metals)surgery
tainted foodNSAIDs
hydroxyethyl starch
  • ๋‚˜์ด, ํ’ˆ์ข…, ์„ฑ๋ณ„์— ๋”ฐ๋ฅธ ์†Œ์ธ(predisposition)์€ ์—†์Œ.

3. Clinical features

  • Anorexia, lethargy (์‹์š•๋ถ€์ง„, ํ—ˆ์•ฝ)
  • Vomiting, diarrhea (๊ตฌํ† , ์„ค์‚ฌ)
  • ๋‹ค์–‘ํ•œ ์†Œ๋ณ€๋Ÿ‰ ๋ณ€ํ™” : Anuria (18%), oliguria (43%), normal urine output (25%), polyuria (14%)
  • uremia์˜ ์ด์ฐจ์  ์ฆ์ƒ์ด๋‚˜, DIC, vasculitis ๋“ฑ์— ์˜ํ•ด AKI ๋ฐœ์ƒ
  • ์‹ฌ๊ฐํ•œ ํ™˜์ž์—์„œ๋Š” seizures(๋ฐœ์ž‘), syncope(์‹ค์‹ ), dyspnea(ํ˜ธํก๊ณค๋ž€)

4. Diagnosis

๊ธฐ์ค€
Signalment
๋ฌธ์ง„ ์ฒญ์ทจ- Ischemic AKI : ์ตœ๊ทผ์˜ trauma, shock, surgery, anesthesia(๋งˆ์ทจ)
- Nephrotoxic AKI : ์ตœ๊ทผ nephrotoxicants์˜ ์„ญ์ทจ๋‚˜ ์ฃผ์ž…
์‹ ์ฒด ๊ฒ€์‚ฌBCS, BP, ์‹ ์žฅ ์ด‰์ง„, ๊ตฌ๊ฐ•/๊ฐ๋ง‰/ํ”ผ๋ถ€/์ง์žฅ ๊ฒ€์‚ฌ
- ์‹ ์žฅ ๋น„๋Œ€์™€ ํ†ต์ฆ (* CKD ๊ธฐ์ €์งˆํ™˜ โ†’ ์‹ ์žฅ ์œ„์ถ• ๊ฐ€๋Šฅ์„ฑ)
- ํƒˆ์ˆ˜, ์ €์ฒด์˜จ์ฆ
* ์‹ ์ฒด๊ฒ€์‚ฌ๋กœ ํ™•์ •์ง“๊ธฐ๋Š” ์–ด๋ ค์›€
CBC
Serum biochemical profile
Urinalysis
Urine culture

5. Treatment

6. Prognosis